Just 37% of companies involved in clinical trials are currently utilizing mHealth technologies, a recent KNect365 survey has revealed.
Based on 261 responses representing pharma, CROs and service providers split across North America, Europe and Asia, the survey results offer an insight into perceptions and implementation of technological innovations in clinical trials today. The results reveal mHealth to be one of the brightest hopes within clinical trials, but also that a number of challenges first need to be overcome before full implementation.